Farid Samaan

Dr. Farid Samaan


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Cadernos de Saude Publica
Verified
Journal Article
Open access
FSFarid Samaan
Farid Samaan
DFDanilo Fernandes
Danilo Fernandes
GKGianna Mastroianni Kirsztajn
Gianna Mastroianni Kirsztajn
RSRicardo de Castro Cintra Sesso
Ricardo de Castro Cintra Sesso
AMAna Maria Malik
Ana Maria Malik
Complications of chronic kidney disease (CKD) can be avoided when promptly diagnosed and treated. The objective was to describe quality indicators of CKD detection and health care in the primary care public service of a city in the State of São Paulo, Brazil. This retrospective study analyzed charts of patients who attended primary care in the public service between November 2019 and February 2020. We selected 10 health quality indicators based on their scientific relevance and availability from the medical records that could express how CKD was identified and managed in primary health care. We estimated the adequate percentage of health indicators with data from 1,066 individuals who had ≥ one risk factor for CKD: hypertension, diabetes, or > 60 years old. Among patients, 79.4% had information on serum creatinine, whereas 58.8% were investigated for proteinuria. Blood pressure data were found in 98.9% of the records. The percentage of patients with blood pressure < 140x90mmHg, glycosylated hemoglobin < 6.5% and LDL-cholesterol < 100mg/dL was 79.2%, 49.2%, and 33.3%, respectively. Renin-angiotensin system blockers were prescribed to 82.8% of the patients with hypertension and CKD. Serum potassium was measured in 35.7% for those who were using renin-angiotensin system blockers. Among those people with CKD, 16.7% had CKD assigned in the medical records as a diagnose. Among those participants at higher risk for CKD, the referral rate to a nephrologist was 31.6%. This study confirmed some missed quality indicators of CKD in primary healthcare. Our results may help administrators develop public policies that improve health care for individuals at high risk for CKD. Long-term follow-up of the health indicators we proposed here will be useful to assess the impact of policy intervention.

14 January 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FSFarid Samaan
Farid Samaan
EPElisa Carneiro de Paula
Elisa Carneiro de Paula
FSFabrizzio Batista Guimarães de Lima Souza
Fabrizzio Batista Guimarães de Lima Souza
LMLuiz Fernando Cardoso Mendes
Luiz Fernando Cardoso Mendes
PRPaula Regina Gan Rossi
Paula Regina Gan Rossi
EBEmmanuel A. Burdmann
Emmanuel A. Burdmann
Introduction: Multicenter studies involving patients with acute kidney injury (AKI) associated with the disease caused by the new coronavirus (COVID-19) and treated with renal replacement therapy (RRT) in developing countries are scarce. The objectives of this study were to evaluate the demographic profile, clinical picture, risk factors for mortality, and outcomes of critically ill patients with AKI requiring dialysis (AKI-RRT) and with COVID-19 in the megalopolis of São Paulo, Brazil.Methods: This multicenter, retrospective, observational study was conducted in the intensive care units of 13 public and private hospitals in the metropolitan region of the municipality of São Paulo. Patients hospitalized in an intensive care unit, aged ≥ 18 years, and treated with RRT due to COVID-19-associated AKI were included.Results: The study group consisted of 375 patients (age 64.1 years, 68.8% male). Most (62.1%) had two or more comorbidities: 68.8%, arterial hypertension; 45.3%, diabetes; 36.3%, anemia; 30.9%, obesity; 18.7%, chronic kidney disease; 15.7%, coronary artery disease; 10.4%, heart failure; and 8.5%, chronic obstructive pulmonary disease. Death occurred in 72.5% of the study population (272 patients). Among the 103 survivors, 22.3% (23 patients) were discharged on RRT. In a multiple regression analysis, the independent factors associated with death were the number of organ dysfunctions at admission and RRT efficiency.Conclusion: AKI-RRT associated with COVID-19 occurred in patients with an elevated burden of comorbidities and was associated with high mortality (72.5%). The number of organ dysfunctions during hospitalization and RRT efficiency were independent factors associated with mortality. A meaningful portion of survivors was discharged while dependent on RRT (22.3%).

1 January 2024 in International Journal of Nephrology
Verified
Journal Article
Open access
FSFarid Samaan
Farid Samaan
CVCristiane Akemi Vicente
Cristiane Akemi Vicente
LPLuiz Antônio Coutinho Pais
Luiz Antônio Coutinho Pais
GKGianna Mastroianni Kirsztajn
Gianna Mastroianni Kirsztajn
RSRicardo de Castro Cintra Sesso
Ricardo de Castro Cintra Sesso
Introduction: The objective of this study was to evaluate quality indicators of secondary health care in chronic kidney disease (CKD).Methods: This retrospective longitudinal study was conducted in an outpatient medical nephrology clinic of the Brazilian Unified Health System (UHS) and a multidisciplinary outpatient clinic of a private health plan (PHP). The inclusion criteria were age ≥ 18 years, ≥ 3 medical appointments, and follow‐up time ≥ 6 months.Results: Compared to PHP patients (n = 183), UHS patients (n = 276) were older (63.4 vs. 59.7 years, p = 0.04), had more arterial hypertension (AH) (91.7% vs. 84.7%, p = 0.02) and dyslipidemia (58.3 vs. 38.3%, p < 0.01), and had a lower estimated baseline glomerular filtration rate (eGFR) (29.9 [21.5–42.0] vs. 39.1 [28.6–54.8] mL/min/1.73 m2, p < 0.01). Compared to PHP patients, UHS patients had a lower percentage of diabetics with glycated hemoglobin < 7.5% (46.1% vs. 61.2%, p = 0.03), fewer people with potassium < 5.5 mEq/L (90.4% vs. 95.6%, p = 0.04), and fewer referrals for hemodialysis with functioning arteriovenous fistula (AVF) (9.1% vs. 54.3%, p < 0.01). The percentages of people with hypertension and blood pressure < 140 × 90 mmHg were similar between the UHS and PHP groups (59.7% vs. 66.7%; p = 0.17), as was the percentage of people with parathyroid hormone control (85.6% vs. 84.8%; p = 0.83), dyslipidemia and LDL‐cholesterol < 100 mg/dL (38.3% vs. 49.3%; p = 0.13), phosphorus < 4.5 mg/dL (78.5% vs. 72.0%; p = 0.16), and 25‐OH‐vitamin‐D > 30 ng/mL (28.4% vs. 36.5%; p = 0.11). The crude reduction in eGFR was greater in the UHS group than in PHP (2.3 [−0.1; 5.9] vs. 1.1 [−1.9; 4.6] mL/min/1.73 m2; p < 0.01). In the multivariate linear mixed‐effects model, UHS patients also showed faster CKD progression over time than PHS ones (group effect, p < 0.01; time effect, p < 0.01; interaction, p < 0.01).Conclusions: Quality of care for patients with CKD can be improved through both services, and multidisciplinary care may have a positive impact on the control of comorbidities, the progression of CKD, and the planning of the initiation of hemodialysis.

16 March 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
FSFarid Samaan
Farid Samaan
BDBruna Bronhara Damiani
Bruna Bronhara Damiani
GKGianna Mastroianni Kirsztajn
Gianna Mastroianni Kirsztajn
RSRicardo de Castro Cintra Sesso
Ricardo de Castro Cintra Sesso
Chronic kidney disease (CKD) provides a worse prognosis for patients with heart disease. In Latin America, studies that analyzed the prevalence and risk stratification of CKD in this population are scarce. We aimed to evaluate CKD prevalence and risk categories in patients of a public referral cardiology hospital in São Paulo, Brazil. This was a cross-sectional study based on a laboratory database. Outpatient serum creatinine and proteinuria results performed between 1 January 2021 and 31 December 2021 were analyzed. CKD was defined by estimated glomerular filtration rate (eGFR) 30 mg/g. A total of 36,651 adults were identified with serum creatinine levels (median age 72.4 [IQR, 51.0–73.6] years, 51% male). Among them, 51.9% had UACR dosage (71.5% with UACR < 30 mg/g, 22.6%, between 30–300 mg/g, and 5.9% with UACR > 300 mg/g). The prevalence of CKD was 30.9% (15.3% stage 3a, 10.2% stage 3b, 3.6% stage 4, and 1.7% stage 5), and the distribution of patients in the risk categories of the disease was: 52.0% with low-risk, 23.5%, moderate risk, 13.0%, high risk, and 11.2%, very high. In an outpatient setting, the prevalence of CKD in cardiological patients was almost three times (31%) that of the general population; about half of the individuals evaluated (48%) were not screened for an important risk marker (proteinuria), and approximately a quarter of these patients (24%) were in the high or very high CKD risk categories.

10 May 2024 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
FSFarid Samaan
Farid Samaan
RSRubens Carvalho Silveira
Rubens Carvalho Silveira
AMAmilton Mouro
Amilton Mouro
GKGianna Mastroianni Kirsztajn
Gianna Mastroianni Kirsztajn
RSRicardo de Castro Cintra Sesso
Ricardo de Castro Cintra Sesso
Although approximately 25% of Brazilians have private health coverage (PHC), studies on the surveillance of chronic kidney disease (CKD) in this population are scarce. The objective of this study was to estimate the prevalence of CKD in individuals under two PHC regimes in Brazil, who total 8,335,724 beneficiaries. Outpatient serum creatinine and proteinuria results of individuals from all five regions of Brazil, ≥ 18 years of age, and performed between 10/01/2021 and 10/31/2022, were analyzed through the own laboratory network database. People with serum creatinine measurements were evaluated for the prevalence and staging of CKD, and those with simultaneous measurements of serum creatinine and proteinuria were evaluated for the risk category of the disease. CKD was classified according to current guidelines and was defined as a glomerular filtration rate (GFR) < 60 ml/min/1.73 m² estimated by the 2021 CKD-EPI equation. The number of adults with serum creatinine results was 1,508,766 (age 44.0 [IQR, 33.9–56.8] years, 62.3% female). The estimated prevalence of CKD was 3.8% (2.6%, 0.8%, 0.2% and 0.2% in CKD stages 3a, 3b, 4 and 5, respectively), and it was higher in males than females (4.0% vs. 3.7%, p < 0.001, respectively) and in older age groups (0.2% among 18-29-year-olds, 0.5% among 30-44-year-olds, 2.0% among 45-59-year-olds, 9.4% among 60-74-year-olds, and 32.4% among ≥ 75-year-olds, p < 0.001) Adults with simultaneous results of creatinine and proteinuria were 64,178 (age 57.0 [IQR, 44.8–67.3] years, 58.1% female). After adjusting for age and gender, 70.1% were in the low-risk category of CKD, 20.0% were in the moderate-risk category, 5.8% were in the high-risk category, and 4.1% were in the very high-risk category. The estimated prevalence of CKD was 3.8%, and approximately 10% of the participants were in the categories of high or very high-risk of the disease. While almost 20% of beneficiaries with PHC had serum creatinine data, fewer than 1% underwent tests for proteinuria. This study was one of the largest ever conducted in Brazil and the first one to use the 2021 CKD-EPI equation to estimate the prevalence of CKD.

1 June 2026 in Brazilian Journal of Nephrology
Verified
Journal Article
Open access
TMThyago Proenca Moraes
Thyago Proenca Moraes
AMAna Flavia Moura
Ana Flavia Moura
ASAndrei C Sposito
Andrei C Sposito
FLFlavia Paiva Proença Lobo Lopes
Flavia Paiva Proença Lobo Lopes
AJAndré Ricardo de Araújo Quadros Junior
André Ricardo de Araújo Quadros Junior
RPRoberto Pécoits-Filho
Roberto Pécoits-Filho
Introduction: Despite advances in chronic kidney disease (CKD) management, early diagnosis and risk stratification remain major challenges. This study analyzed national data derived from a Brazilian CKD screening campaign, targeting high-risk individuals unaware of their condition, to estimate CKD prevalence and evaluate longitudinal trends in estimated glomerular filtration rate (eGFR). Methods: This cross-sectional, observational study evaluated adults with diabetes mellitus (DM) and/or arterial hypertension, previously undiagnosed with CKD, who participated in a CKD screening campaign. Demographic, clinical, and laboratory data—including serum creatinine and albumin-to-creatinine ratio (ACR)—were collected. CKD staging followed Kidney Disease: Improving Global Outcomes (KDIGO) criteria, and eGFR was calculated using the CKD-EPI 2021 equation. Mixed effect models were used to assess eGFR trajectories and logistic regression was used to examine CKD risk factors. Results: Among 14,239 high-risk participants (mean age 54 years; 84% hypertensive; 37% diabetic), CKD was newly identified in 19.6%, with 11.3% showing eGFR 30 mg/g. Despite abnormal ACR results, testing remained uncommon: <5% prior to the campaign and 65 years of age (+17%), and individuals with body mass index (BMI) >25 kg/m2 (+60%). Logistic regression models of risk projected ~169,000 kidney failure cases in 2 years and ~500,000 in 5 years, excluding competing mortality risk. Conclusion: A high prevalence of previously undiagnosed CKD was found in this high-risk population. Despite universal access to testing in Brazil, albuminuria remains markedly underused, representing a missed opportunity for early detection and implementation of nephroprotective interventions.